Hospitals & Healthcare News

This section covers the managerial aspects in the Healthcare industry.

Novogen Acquires Privately-held Neuro-oncology Company to Support Development of GDC-0084 in Glioblastoma

Monday, October 31, 2016

Australian oncologyfocused biotechnology company Novogen Ltd announced that it has fullyacquired Glioblast Pty Ltd a privatelyheld neurooncologyfocused Australian biotechnology company The transaction includes an upfront payment of AU 21 million comprising AU 600000 in cash and ordinary fullypaid s..

After India, European Union to probe Wanbury Pharma for illegal export

Monday, October 31, 2016

Wanbury Pharma one of the largest exporters of diabetes drug metformin has come under the lens of the European Medicines Agency EMA after the Maharashtra Food and Drug Administration launched an investigation of illegal packaging of drugs The Mumbaibased drug maker was served a show cause notice by..

TaiGen Biotechnology To Establish a New Company With HEC Pharmaceutical in China for Treatment of Chronic Hepatitis C

Monday, October 31, 2016

TaiGen Biotechnology Co Ltd announced that its wholly owned subsidiary TaiGen Biopharmaceuticals Co Beijing Ltd has signed an agreement with YiChang HEC ChangJiang Pharmaceutical Co Ltd HEC to establish a new company Newco in mainland China for the joint development manufacturing and commercializati..

FDA spurns Sanofi, Regeneron arthritis drug due to manufacturing lapses

Saturday, October 29, 2016

Sanofi SA and Regeneron Pharmaceuticals Inc on Friday said US regulators had declined to approve their experimental treatment for rheumatoid arthritis because of manufacturing deficiencies The companies in a release said the US Food and Drug Administration identified the deficiencies during a routi..

Amyris Enters Collaboration with Top 10 Pharmaceutical Company for Biosynthetic Drug Discovery

Saturday, October 29, 2016

Amyris Inc the industrial bioscience company is pleased to announce it has entered into a research agreement with a commercial license option with one of the top 10 largest global pharmaceutical companies Under the terms of the agreement the collaboration will use Amyris39s PharmTM platform technolo..

Astellas to Acquire Ganymed Pharmaceuticals

Friday, October 28, 2016

Astellas Pharma Inc and Ganymed Pharmaceuticals AG a biopharmaceutical company located in Mainz Germany which focuses on the development of antibodies against cancer announced today that Astellas and Ganymeds shareholders have entered into an agreement for Astellas to acquire Ganymed The transaction..

China Resources Pharma Falls in Hong Kong After $1.8 Billion IPO

Friday, October 28, 2016

China Resources Pharmaceutical Group Ltd fell in its Hong Kong trading debut after raising about 18 billion in the largest initial public offering globally from a drugmaker since 2013 The stock traded 35 percent lower at HK878 at 944 am in Hong Kong The Beijingbased company priced its IPO at HK910 ..

Aerie Pharma reports positive topline results of late stage study of Rhopressatm

Friday, October 28, 2016

Aerie Pharmaceuticals reports positive topline efficacy results of ROCKET 4 phase 3 trial of Rhopressatm netarsudil ophthalmic solution 002 percent Aerie Pharmaceuticals Inc Study successfully achieves primary efficacy endpoint Aerie Pharmaceuticals Inc Company separately announces withdrawal of..

AstraZeneca pauses two cancer drug trials' enrolment due to bleeding

Friday, October 28, 2016

AstraZeneca39s high hopes for cancer immunotherapy were dented on Thursday as the recruitment of new patients with head and neck cancer into two clinical studies was put on hold following instances of bleeding The drugmaker said the US Food and Drug Administration FDA had placed a partial hold on e..

Auven Therapeutics Announces Sale of Ocular Technologies to Sun Pharma

Thursday, October 27, 2016

Auven Therapeutics an international private equity company focused on accelerated development of breakthrough therapeutic drugs today announced the execution of definitive agreements for the sale of 100 percent of Ocular Technologies Sarl a wholly owned Auven subsidiary through which all SecieraTM O..

EpiPen rival plans return to U.S. market in first-half 2017

Thursday, October 27, 2016

Privately held drugmaker Kaleo Inc announced on Wednesday plans for a US relaunch of its AuviQ injector for lifethreatening allergic reactions in the first half of next year AuviQ designed to deliver the same epinephrine drug as Mylan NV39s EpiPen was recalled from the market last year amid concern..

Minerva Neurosciences posts positive data on schizophrenia drug

Thursday, October 27, 2016

Minerva neurosciences announces positive data from sixmonth extension of phase iib trial of min101 monotherapy in schizophrenia Minerva neurosciences min101 was reported to be well tolerated at both doses over entire 36week duration of study by schizophrenic patients Minerva neurosciences positive..

Horizon Pharma plc Completes Acquisition of Raptor Pharmaceutical Corp.

Thursday, October 27, 2016

Horizon Pharma plc HZNP a biopharmaceutical company focused on improving patients39 lives by identifying developing acquiring and commercializing differentiated and accessible medicines that address unmet medical needs today announced that it has completed the acquisition of Raptor Pharmaceutical Co..

Nordic Nanovector and Heidelberg Pharma enter collaboration to develop novel antibody-drug conjugates (ADCs)

Wednesday, October 26, 2016

Nordic Nanovector ASA announces it has entered into a collaboration with Heidelberg Pharma GmbH a subsidiary of biopharmaceutical company WILEX AG FSE WL6 specializing in the development of antibodydrug conjugates ADCs to develop novel ADCs for treating leukaemias Leukaemias are orphan diseases with..

Novartis CEO sees tougher U.S. drug pricing over next three-five years

Wednesday, October 26, 2016

Novartis expects a more difficult pricing environment for drugs in the United States in the years ahead its chief executive told a results conference call on Tuesday We expect pricing to become more difficult in the US over the next three to five years Joe Jimenez said Both major US presidential c..

Serodus: Orphan Drug Designation for SER100 in PAH

Wednesday, October 26, 2016

Serodus ASA Said on Tuesday Office of Orphan Products Development United States Food and Drug Administration FDA has granted Orphan Drug Designation for SER100 in pulmonary arterial hypertension PAH Subject to financing Serodus will plan for first clinical study either in Phase IIa study or as adap..

GSK files potential $1 billion shingles vaccine for U.S. approval

Tuesday, October 25, 2016

GlaxoSmithKline has filed its shingles vaccine Shingrix for US regulatory approval the drugmaker said on Monday bringing the potential 1 billionayear seller a step closer to market Shingrix is viewed by analysts as among the British company39s most promising experimental products since it has shown..

Herantis Pharma plc and Renishaw plc sign collaboration agreement on Parkinson’s study

Tuesday, October 25, 2016

Herantis Pharma plc and Renishaw plc have signed a collaboration agreement related to the first clinical study of CDNF in Parkinsons disease Under the agreement the Drug Delivery System developed by Renishaw will be used for the clinical administration of CDNF Herantis and Renishaw will jointly cont..

FDA approves Merck's lung cancer drug as first-line treatment

Tuesday, October 25, 2016

Merck Co Inc on Monday said the US Food and Drug Administration has approved its immunotherapy Keytruda for use in certain previously untreated lung cancer patients making it the only approved firstline treatment The drug has been approved for treating metastatic nonsmall cell lung cancer NSCLC pa..

Oasmia Pharmaceutical buys cancer project from Karo Pharma

Tuesday, October 25, 2016

Oasmia Pharmaceutical and Karo Pharma have entered into an agreement concerning Karo Pharma39s cancer project KB9520 which has shown promising results in preclinical models for a number of different types of cancer Oasmia acquires the project and strengthens its oncology project portfolio Karo Pha..

TOP